首页|期刊导航|中国肺癌杂志|癌症神经科学视角下肺癌演进的神经调控机制与临床治疗挑战

癌症神经科学视角下肺癌演进的神经调控机制与临床治疗挑战OA

Neuroregulatory Mechanisms of Lung Cancer Progression and Clinical Treatment Challenges from the Perspective of Cancer Neuroscience

中文摘要英文摘要

肺癌作为全球发病率与死亡率均居首位的恶性肿瘤,其演变进程与神经系统存在高度复杂的双向调控关系.神经系统在肺癌的起源阶段发挥关键调控作用,可通过神经元、神经递质及神经活性分子等核心介导途径,参与肺癌细胞增殖、局部侵袭及远处转移等恶性生物学行为的调控;与此同时,肺癌本身及相关治疗干预措施亦能反向诱导神经系统的结构重塑与功能重编程.癌症神经科学这一新兴交叉学科的崛起,为突破肺癌治疗瓶颈提供了全新的研究视角,但同时也面临诸多亟待解决的理论与临床挑战.本文系统梳理神经系统与肺癌演进的内在关联,重点剖析局部治疗、化疗、免疫治疗及靶向治疗等临床策略对神经系统的潜在影响及其分子机制,进一步明确该领域的研究机遇与核心挑战,旨在为优化肺癌精准治疗体系、提升临床治疗效能提供理论依据与实践参考.

Lung cancer is the leading cause of cancer morbidity and mortality worldwide.A highly complex bidirec-tional regulatory relationship exists between lung cancer progression and the nervous system.The nervous system is believed to play a pivotal regulatory role in the genesis of lung cancer.It is involved in regulating malignant biological behaviors such as proliferation,local invasion,and distant metastasis of lung cancer cells via core mediating pathways involving neurons,neu-rotransmitters,and neuroactive molecules.At the same time,lung cancer itself and related therapeutic interventions are capable of inducing reverse structural and functional reprogramming within the nervous system.The emergence of cancer neuroscience as a novel interdisciplinary field offers a new perspective to overcome the current bottlenecks in lung cancer treatment,yet it also faces numerous theoretical and clinical challenges that urgently require resolution.This article systematically reviews the intricate relationship between the nervous system and lung cancer progression,focusing on the potential effects and molecular mechanisms of clinical strategies including local therapies,chemotherapy,immunotherapy,and targeted therapy on the nervous system,with the aim of clarifying research opportunities and key challenges in this field and providing a theoretical foundation and practical reference for optimizing the precision treatment system of lung cancer and improving clinical efficacy.

王娜;张波;尚立涵;王雪瑞;王小杉;范琪钰;王超然;孔凡铭

300381 天津,天津中医药大学第一附属医院,中医国家临床医学研究中心,天津市中医肿瘤研究所300381 天津,天津中医药大学第一附属医院,中医国家临床医学研究中心,天津市中医肿瘤研究所300381 天津,天津中医药大学第一附属医院,中医国家临床医学研究中心,天津市中医肿瘤研究所300381 天津,天津中医药大学第一附属医院,中医国家临床医学研究中心,天津市中医肿瘤研究所300381 天津,天津中医药大学第一附属医院,中医国家临床医学研究中心,天津市中医肿瘤研究所300381 天津,天津中医药大学第一附属医院,中医国家临床医学研究中心,天津市中医肿瘤研究所300381 天津,天津中医药大学第一附属医院,中医国家临床医学研究中心,天津市中医肿瘤研究所300381 天津,天津中医药大学第一附属医院,中医国家临床医学研究中心,天津市中医肿瘤研究所

肺肿瘤癌症神经科学神经系统神经活性分子

Lung neoplasmsNeuroscienceNeuro-oncologyNeuroactive molecule

《中国肺癌杂志》 2026 (3)

208-220,13

This paper was supported by the grants from Noncommunicable Chronic Diseases-National Science and Technology Major Project(No.2024ZD0521103,to Fanming KONG),Science and Technology Project of Haihe Laboratory of Modern Chinese Medicine(No.GZY-KJS-2025-056,to Fanming KONG),and Tianjin Public Health Science and Technology Major Youth Project(No.24ZXGQSY00090,to Fanming KONG),Pilot Demonstration Project for the Inheritance and Innovative Development of Traditional Chinese Medicine in Nankai District, Tianjin (No.20240204020, to Chaoran WANG) and First Teaching Hospital of Tianjin University of Traditional Chinese Medicine "Tuoxin Project" (No.2023008, to Chaoran WANG).本文受四大慢病重大专项(No.2024ZD0521103)、现代中医药海河实验室科技项目(No.GZY-KJS-2025-056)、天津市公共卫生科技重大专项青年项目(No.24ZXGQSY00090)、天津市南开区中医药传承创新发展示范试点项目(No.20240204020)及天津中医药大学第一附属医院"拓新工程"基金科研课题(No.2023008)资助

10.3779/j.issn.1009-3419.2026.106.07

评论